The Femtech IP Landscape – Where Do We Stand?
October 14, 2020 at 1:30 pm – 2:30 pm
Last year, investors poured a reported $241+ million into women’s health tech, but how much of that has gone into IP? And, how does that compare historically to investments in IP for health companies? This event opens the floor to a candid discussion of how and why IP plays a role in the future of femtech.
Sara Fish, IP Attorney – Associate, Fish & Richardson
Jacqueline Tio, IP Attorney – Principal, Fish & Richardson
About Fish & Richardson
Fish & Richardson is one of the world’s premier intellectual property and litigation firms, working with small and large clients to integrate, protect, and enforce intellectual property rights that complement business objectives. With 400+ attorneys and technology specialists possessing technical expertise ranging from biology to quantum field theory, Fish prides itself on the ability to provide the depth of expertise needed, both technically and legally, to enable the success of its clients. Fish is committed to promoting diversity not only from within, but also from its clients, and is proud to be a supporter of femtech initiatives and women’s health technology.